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Many survivors of stroke experience arm impairments, which can severely impact their quality of life. Forcing use of
the impaired arm appears to improve functional recovery in post-stroke hemiplegic patients, however the
mechanisms underlying improved recovery remain unclear. Animal models of post-stroke rehabilitation could prove
critical to investigating such mechanisms, however modeling forced use in animals has proven challenging.
Potential problems associated with reported experimental models include variability between stroke methods,
rehabilitation paradigms, and reported outcome measures. Herein, we provide an overview of commonly used
stroke models, including advantages and disadvantages of each with respect to studying rehabilitation. We then
review various forced use rehabilitation paradigms, and highlight potential difficulties and translational problems.
Lastly, we discuss the variety of functional outcome measures described by experimental researchers. To conclude,
we outline ongoing challenges faced by researchers, and the importance of translational communication. Many
stroke patients rely critically on rehabilitation of post-stroke impairments, and continued effort toward progression
of rehabilitative techniques is warranted to ensure best possible treatment of the devastating effects of stroke.Introduction
In 1973, Norwegian neuroscientist Alf Brodal wrote:
“since regeneration of transected central axons has never
been convincingly demonstrated in higher mammals, it
seems in most instances that one must resort to the as-
sumption that intact fibres ‘take over’ for the damaged
ones” [1]. Although this portrays part of the story, dec-
ades later we now know that there are a number of pro-
cesses involved in post-injury neuroplasticity, causing a
significant shift in the way we think about neurorehabil-
itation. As research into the complicated phenomenon
of functional recovery and use-dependent reorganization
in the brain continues, the importance of valid animal
models of post-stroke rehabilitation has become clear.
Almost 850,000 North Americans experience a stroke
each year [2,3]. In addition to a high mortality rate, the
majority of those who survive a stroke are left with
motor disabilities [3], such as upper extremity impair-
ments. Many patients remain chronically impaired in the* Correspondence: tasker@upei.ca
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distribution, and reproduction in any mediummonths and years following a stroke, which vastly
impacts quality of life and contributes to post-stroke de-
pression [4]. With an aging population, a drastic increase
in the societal burden of stroke can be expected if pro-
gressive improvements in stroke treatment and post-
stroke rehabilitation are not made.
While preventive therapies and lifestyle modifications
are known to reduce the incidence of stroke and asso-
ciated mortality [5], the only effective drug presently
available to treat stroke is tissue plasminogen activator
(tPA). TPA works only in the event of ischemic stroke,
by dissolving the offending blood clot to restore blood
flow and prevent further damage. However, it is effective
only in a fraction of stroke patients [6] due in part to a
narrow therapeutic time window [7,8]. Neuroprotective
drugs are effective in experimental settings, but to date,
none have proven clinically effective [9]. Hence, contin-
ued effort toward progression of rehabilitative techni-
ques and enhanced communication between clinical and
experimental researchers is warranted to ensure best
possible care and recovery of patients who suffer the
devastating effects of a stroke.e BioMed Central Ltd. This is an Open Access article distributed under the terms
(http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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One rehabilitative technique that has been developed to
increase use and improve function of the upper limb in
survivors of stroke is constraint induced movement
therapy (CIMT) [10]. The therapy discourages ‘learned
non-use’ , first described by Taub et al. [11]. Learned non-
use is a phenomenon whereby movement is initially
suppressed due to failure and adverse consequences
encountered when a subject attempts to use the affected
limb. This results in persistent compensatory behaviours
and subsequent suppression of use of the impaired limb,
even when function may eventually be possible (Figure 1).
Through constraint of the unaffected limb and subsequent
forced use of the affected one, CIMT encourages positive
feedback about the limb’s functional potential. Generally,
the constraint device is worn for most waking hours during
a two week period [12,13], and is accompanied by intensive
repetitive task practice (RTP) performed daily using the
(unconstrained) impaired limb. RTP is performed in con-
junction with shaping, during which participants engage in
meaningful functional activities with measurable progres-
sions for which they receive positive feedback as the activ-
ities become increasingly difficult. In addition to shaping,
other behavioural techniques such as home practice and
problem solving sessions are used to aid in the transfer of
functional gains to performance of daily activities [14].Figure 1 Following injury to the forelimb, attempts to use the
impaired limb lead to unsuccessful motor attempts. The
consequences include pain and failure, creating negative feedback
which leads to suppression of the behaviour. Meanwhile, the
unaffected or less affected forelimb is used with higher success,
leading to reinforced compensation. Together, these constitute the
phenomenon of learned non-use. Adapted from Taub et al. [11].CIMT has been clinically shown to improve functional
outcome [10,12,13,15,16], even when administered to
patients with chronic deficits [17], however, the therapy
presents several obstacles. CIMT is expensive due to the
intensive therapy requiring specialized professionals.
Moreover, despite the fact that subjects are required to
sign a ‘behavioural contract’ [15,18], designed to increase
incentive and ensure motivation, CIMT is a demanding
therapy for stroke patients who have diminished physical
capacity. This raises concerns about compliance issues
[19], and several modifications of the therapy have been
investigated in an attempt to reduce the intensity of the
therapy [20-22]. While results of these studies are prom-
ising, larger confirmatory research is required. Further,
the procedure has been developed for and tested in
patients that retain some level of function, according to
a general inclusion/exclusion criteria that include the
ability to initiate finger movements [15], and extension
movement of at least 20 degrees in the wrist and fingers
[13,17,22]. This limits the generalization of study results
to all stroke patients that are hemiparetic [23,24].
Experimental rehabilitation in animals: opportunities and
challenges
Valid experimental models are essential for the develop-
ment of rehabilitative therapies to treat survivors of
stroke. Mechanisms underlying functional recovery exist
at cellular, circuit, and system levels, and should be
examined at each. By modeling CIMT in animals, it may
be possible to elucidate underlying processes responsible
for functional benefits, and eventually manipulate these
processes to accelerate or enhance post-stroke recovery.
Indeed, there have been several attempts at the develop-
ment of animal models of rehabilitation that resemble
CIMT [25-30]. These have provided important insights
into the numerous variables that need to be considered,
such as 1) the choice of an appropriate animal model of
stroke, 2) development of rehabilitation models that best
model particular and appropriate aspects of the regimen,
and 3) appropriate identification and interpretation of
outcome measures. This review provides an overview of
these variables, and addresses considerations and limita-
tions of each.
Animal models of ischemic stroke
In-depth investigation into the complicated processes
underlying functional recovery relies critically on the use
of live whole animals. A variety of animal models includ-
ing pigs [31] and non-human primates [32] have been
explored, but rat models of stroke are by far the most
common choice for researchers. This is largely due to
the similar neurovascular branching to humans [33,34],
relatively low cost [35], and high number of validated
behavioural tests of functional outcome in the rat
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rats are especially valued for the similarities to the limb
movements of the human arm [37].
When choosing a rat model of stroke, further consid-
eration must be given to inter-strain differences. Experi-
mental stroke performed identically in different strains
of rats can produce markedly different damage [38], and
each can respond differently to post-stroke treatments
[39]. With several strains to choose from (e.g. Sprague
Dawley, Wistar, Long Evans), it is important to optimize
the chosen model to a chosen strain. Ultimately, the
choice is usually a matter of personal preference, and
several strains are acceptable, however caution should to
be applied when interpreting results obtained using one
strain relative to other studies using other strains.
A further consideration is the age of the animals to be
used in the study. Although clinical stroke occurs largely
in the elderly, using aged animals in experimental set-
tings presents challenges. Increased post-surgical mortal-
ities [40,41], the need for more intensive post-operative
care [42], and the greater investment of resources
required to age the animals make them less than ideal
subjects in basic research. For these reasons, the major-
ity of post-stroke studies are done on young adult ani-
mals (~4 months old). There is increasing criticism of
this practice, however, as some argue that the use of
young animals is less clinically relevant, and may con-
tribute to issues with translating research findings
[9,40,43,44].Experimental stroke models
Stroke is an extremely diverse condition, and there is no
ideal experimental stroke model. Rather, it is important
to consider how well a particular model will address a
specific experimental question. Criteria to consider in-
clude pathophysiological processes, lesion size and re-
producibility, and physiological variables that can be
monitored and maintained.
All experimental stroke models are associated with
some variability in lesion size and location, especially
important parameters when studying rehabilitation. Be-
cause recovery of function is largely attributed to numer-
ous neuroplastic changes on a cellular level [45-47], it is
important to ensure sufficient unaffected or salvageable
tissue remains to act as a substrate for recovery pro-
cesses. Furthermore, some stroke model complications
can have a direct impact on behavioural outcome. For
example, poor overall health due to loss of body weight,
stress from surgery, infections, and collateral damage to
a non-targeted brain area (e.g. those associated with cog-
nitive function) can all impair functional performance.
These factors must be considered when choosing a
stroke model for evaluation of rehabilitation.Middle cerebral artery occlusion by intraluminal filament
The middle cerebral artery (MCA) is often affected in is-
chemic stroke, hence the development of the most com-
monly used animal stroke model: middle cerebral artery
occlusion (MCAo). This approach aims to cause ische-
mia to the targeted area of the brain by occluding this
downstream major vessel. The MCA can be accessed via
the internal [48] or external [49] carotid artery, and
occluded temporarily [49] or permanently [50]. Transi-
ent MCAo is achieved by temporary insertion of a fila-
ment into the MCA, which is later removed resulting in
blood flow restoration. Permanent MCAo involves leav-
ing the filament in the MCA, or using a clip to perman-
ently occlude blood flow.
MCAo does not require an invasive craniectomy, as
arteries are accessed at a midline ventral incision point.
Infarcts often comprise both cortical and striatal dam-
age, a common pathology following stroke [51]. How-
ever there can be non-targeted damage to brain regions
outside the vascular territory of the MCA [52], and asso-
ciated unintended behavioural impairments [45]. During
external carotid artery occlusion, facial muscles may be
affected by ischemia, leading to feeding problems, weight
loss, and mortality. Furthermore, even subtle variations
in surgical technique can have an impact on outcome,
largely contributing to the variability inherent in the
model [53].
Endothelin-1
Endothelin-1 (ET-1) is a potent vasoconstrictor that can
be used to induce ischemia directly when applied topic-
ally [54,55] or injected intracerebrally [56,57] or indir-
ectly if injected proximal to the MCA [58]. ET-1 affects
arteries in the immediate area of injection, and causes a
rapid and temporary reduction in blood flow followed by
reperfusion over several hours [33], making it more rep-
resentative of the clinical condition compared to the im-
mediate reduction and reperfusion associated with
MCAo [59]. An advantage of this model is the ability to
‘fine tune’ infarcts by adjusting the concentration, vol-
ume, and stereotaxic placement of the microinjections.
This even allows researchers to model white matter
damage, thought to be relevant to lacunar infarctions
observed in many stroke patients [60]. Infarcts achieved
using this model can be more localized than those
resulting from traditional MCAo, and have been shown
to result in long-lasting behavioural deficits [43,56,57].
However, the exact mechanism of vessel occlusion is not
well characterized, and occlusion duration is not easily
controlled.
Photothrombosis
Photothrombotic stroke models induce cortical damage
by the systemic injection of a photoactive dye (e.g. Rose
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method can be used to produce widespread damage by
targeting the middle cerebral artery [62,63], or to pro-
duce more localized lesions by application to the vascu-
lature directly in the targeted brain area [29,61,64,65].
This results in the generation of free radicals, leading to
focal damage, platelet activation, and aggregation in ves-
sels within the irradiated area, resulting in ischemia.
Photothrombosis allows the experimenter to easily tar-
get precise regions of irradiation, and results in relatively
reproducible lesions. This method is associated with a
low mortality rate and consistent infarcts with precise
location and size [64]. Because the photoactivation
occurs through a thinned area of skull, craniectomy is
not necessary. However, because the model is based on
photoirradiation through the skull onto the brain sur-
face, the resulting infarct is only cortical. Furthermore,
this model does not produce a penumbral region that
resembles that observed in clinical stroke [66].
Devascularization
Devascularization of the cortex can be achieved by pial
stripping, a process whereby surface vasculature is phys-
ically removed [67-69], for example by rubbing. The




+Models transient or permanent ischemia;
+No craniectomy required;
+Results in cortical and striatal damage




+Can produce cortical and striatal damage;
+Ability to control precise variables (e.g. concentra
volume, stereotaxic coordinates) resulting in locali





+Models permanent ischemia; low mortality rate;
+Precise control over lesion size and location (dire




+Relatively good control over lesion size location;
A summary of the advantages and disadvantages of several commonly used modebeneath the devascularized area. Though relatively well-
controlled, there can be mechanical damage to sur-
rounding tissue and vessels, resulting in hemorrhage
[59]. Like photothrombosis, this method does not permit
reperfusion [59].
Other stroke models
The stroke models described above are those most com-
monly used to study post-stroke rehabilitation paradigms
(see Table 1 for summary). There are several other mod-
els of focal ischemia that are widely used for other
aspects of stroke research such as embolization and
spontaneous infarction using hypertensive rats [34], as
well as of multi-focal, global ischemia, and hemorrhagic
models (for comprehensive reviews, see [59,70]).
Choosing a model of rehabilitation
Over the past two decades several creative animal mod-
els of forced use therapies have been developed, however
the major challenge researchers face is that of subject
motivation. As highlighted above, CIMT involves con-
straint of the nonparetic limb for most waking hours,
which forces use of the impaired limb for daily tasks as
well as intensive therapist-led exercises. In rats, this pre-
sents a challenge. Certainly, the affected forelimb can beion
Disadvantages References
-Large and variable infarcts; [48,49,51,52,71]
-Collateral damage due to non-
targeted vasculature;
-Feeding problems may occur;
-Some mortality
-Requires removal of some skull
tissue;
[55-58,72]




-Mechanism of vessel occlusion not
well elucidated
-Requires skull thinning (direct); [61,63-66]
ct); -Can only produce cortical damage
(direct);
-Collateral damage to non-targeted
areas (indirect)
-No penumbra
-Requires removal of skull tissue; [59,67-69]
-Mechanical damage can occur to
surrounding tissue and vessels;
-Can produce surface damage only;
-No penumbra
ls of experimental stroke.
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[57,73,74] and lack of behavioural pressure to rely on
the impaired forelimb [27,57] can be problematic. Some
researchers have opted to shift focus away from con-
straint per se and toward forced use. Many also incorp-
orate task-specific exercises to model the RTP associated
with CIMT. However, this results in the need to ‘trade
off ’ aspects of the rehabilitation, in an attempt to repli-
cate specific components of therapy. For example, ex-
perimental rehabilitation may require unconstrained
bilateral (rather than unilateral) forced use, or less-
intense voluntary paradigms to reduce animal stress and
increase behavioural incentive. As noted by Taub and
Uswatte [18], the ‘constraint’ used in CIMT is intended
as a means to induce patients to use the affected extrem-
ity for a large proportion of the time and for a variety of
activities, thus other strategies that induce similar pres-
sures are likely to result in similar use-dependent
reorganization and functional benefit. Some of the more
common techniques used in animals are summarized in
Table 2 and described below.
Constraint
The principle behind this strategy is straightforward: con-
strain use of the unaffected forelimb, thereby forcing the
animal to use the affected forelimb. Debow et al. [27] de-
scribe employing a sleeveless jacket, wrapped around the
upper torso of the rat and attached to a metal wrist brace-
let. A major benefit of this paradigm is that the duration
of the restraint is easily controlled; i.e. the bracelet was
clipped to the jacket for 8 hours/day. The disadvantage is
that the continuous wearing of the jacket and the
complete restriction of the unaffected forelimb for most of
the day could exacerbate animal stress.
A more permanent paradigm of constraint is plaster
casting, whereby following stroke surgery, the affected
forelimb is plastered to the torso [25,26,75]. Like theTable 2 Models of experimental forelimb rehabilitation
Rehab model Advantages
Constraint +Most direct model of CIMT;
+Allows constraint for specific durations thereby allowing
the evaluation of various durations of therapy;
+Conducive to studies of unilateral forced use
Forcing use
with locomotion








+An addition to rehabilitation that models task specific
shaping exercises of CIMT
Summary of advantages and disadvantages of previously described animal modelsconstraint jacket, this could result in animal stress and
ultimately confound results, and these paradigms alone
may not create the behavioural pressure required to in-
tensely force use of the impaired forelimb.
Forcing use by locomotion
Some researchers have focused directly on forcing use of
the impaired limb, exploiting the fact that in order to run
or walk, animals need to engage the impaired forelimb to
some degree. The intensity of such therapies varies from
10–60 minutes of locomotion (and from < 1 km to 7 kms
per day) and lasts 3–5 weeks [25,27,57,76-81]. This form
of rehabilitation can be involuntary, using motorized run-
ning wheels or treadmills [44,74,76,78-80,87], or volun-
tary, by allowing free access to running wheels [77,81,87]
or pet activity balls [57].
In the voluntary models, the use of the impaired fore-
limb may still be considered ‘forced’ because of the ne-
cessity to engage the impaired forelimb to perform the
movement, while the appetitive nature of the activity is
believed to reduce the stress experienced by the animal
[74]. Because movement is voluntary, the experimenter
has less control over rehabilitation intensity, however
the resulting self-inflicted intensity could be regarded as
an additional measure of performance [57,81]. There is
some evidence that a voluntary rehabilitation paradigm
may exert a more beneficial effect than involuntary [74].
Encouraging use with enriched environment
In 1947, neuroscientist Donald Hebb noted that labora-
tory rats that had been taken home as pets had better
learning and problem-solving skills that those who lived
in standard laboratory conditions [88]. This prompted
research into enriched environments (EEs) which have
since been found to enhance sensory, cognitive, and so-
cial stimulation, as well as improved recovery following
stroke [82-85,89].Disadvantages References
-Constraint devices may be stressful,
confounding results;
[25,27,75]
-Lack of behavioural pressure to use paretic arm
despite constraint
-Can be stressful (involuntary forced use); [27,57,76-81]
-May lack control over intensity (voluntary forced
use);
-Complicated by other non-forced use therapy
components such as cognitive stimulation;
[82-86]
-Usually involves bilateral forced use




Figure 2 A task-specific reaching exercise can be administered using an apparatus such as this. By piling palatable sugar pellets to one
side of the box (opposite from the impaired forelimb) rats are encouraged to use the impaired limb to reach through the center slot. The
intensity can be altered by controlling the accessing time, number of pellets, and height of the reaching box.
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ample opportunity for engagement in voluntary nonspe-
cific activity, as a major component of these environ-
ments is the presence of novel objects and climbing
apparatuses. As such, they generally encourage voluntary
movement in a way that stimulates use of the impaired
forelimb. While the contribution of the motor enrich-
ment component of EE to functional recovery has yet to
be elucidated, this environment represents a basic volun-
tary use paradigm that has shown significant positive
results when scrutinized by systematic review [89].Task specific exercises
CIMT includes RTP exercises that involve grasping,
gripping, and manipulating objects [12,13], therefore
many experimental researchers combine a form of re-
habilitation described above with a task specific exercise
[27,57,76,77,82,83,86,90,91]. Experimentally, these RTP
exercises are often modeled using pellet reaching tasks.
Animals are provided palatable sucrose pellets that re-
quire reaching with the impaired limb. This can be
achieved by placing pellets on the appropriate side of a
tray, shelf, or well [57,77,83,90] (Figure 2), or by using a
modified staircase apparatus (described in Reaching
Tests) wherein the descending stairs have been replaced




NSS Awards an overall score for
determining general deficit
+Encompasses a range of
assessments, then compiles
a single measure
Cylinder test Assesses spontaneous forelimb
use
+Fast and easy to administ






independent use of forelimbs
+Easy to administer;
+Allows for analysis of both
distance and forepaw dexte
Single pellet
reaching task
Assesses forelimb dexterity +Allows for in-depth analys











Assesses postural reflex +Fast and easy to administ
Forelimb
placing test
Assesses forelimb function and
placing deficits
+Fast and easy to administ
A summary of advantages and disadvantages of various tests of functional deficit aInitiating rehabilitation
While CIMT is generally initiated as soon as the patient is
medically stable, it is effective when initiated even several
years post-insult [17,21]. However, some animal studies
have shown that early initiation of rehabilitation can result
in larger infarcts and worse functional outcome [28,92].
Therefore, it is recommended that therapy be delayed
until several days post-infarction. Unlike humans, rats also
exhibit spontaneous recovery on many functional tests in
a relatively short time frame; delaying rehabilitation too
long may result in missed opportunity to accelerate that
recovery. Generally, experimental rehabilitation is initiated
between post surgical day 3 and 7 [27,57,76,77,83,85,86].
The time course of post-ischemic plasticity is intercon-
nected with the cascade of events that occur on a cellu-
lar level in the brain following stroke. The surviving
tissue constitutes a growth promoting microenviron-
ment [45,47,93,94] wherein the expression of survival,
repair, and plasticity genes are temporally expressed
[94]. In the first days following ischemia, there is reso-
lution of edema and diaschisis, followed by altered ex-
pression of growth-stimulating and -inhibitory genes.
Further, a diverse immunological response is initiated,
the role of which remains controversial. Inflammation
and activation of microglial and other immunological





-Does not inform about the nature of specific deficits;
er; -Video analysis can be time intensive
mber of
-Intensive tests training which requires food deprivation;
-May confound results of task-
reaching
rity
specific rehabilitation if performed often
is of the
lating a
-Intensive tests training which requires food deprivation;
-May confound results of task-specific rehabilitation if
performed often
ind limb -Can be complicated by post-surgical immobility
er -Measures only postural reflexive position,
-Only awards a 0–2 score.
er -Measures only reflexive sensorimotor response;
-Can be difficult to distinguish between reflexive response
and initiated movement, therefore experimenter must be
experienced at determining validity
nd recovery.
Table 4 Generalized neurological severity score
Motor tests (maximum 6)
Raising rat by tail (maximum 3)
Flexion of forelimb 1
Flexion of hindlimb 1
Head moved >10° to vertical axis within 30 s 1
Placing rat on floor (maximum 3)
Normal walk 0
Inability to walk straight 1
Circling toward paretic side 2
Falls down to paretic side 3
Sensory tests (maximum 2)
Placing test (visual and tactile test) 1
Proprioceptive test (pushing paw against table edge) 1
Beam balance tests (maximum 6)
Balances with steady posture 0
Grasps side of beam 1
Hugs beam and 1 limb falls down from beam 2
Hugs beam and 2 limbs fall down from beam, or spins on beam
(60 s)
3
Attempts to balance on beam but falls off (40 s) 4
Attempts to balance on beam but falls off (20 s) 5
Falls off; no attempt to balance or hang on to beam (20 s) 6
Reflex absence and abnormal movements (maximum 4)
Pinna reflex (head shake when auditory meatus is touched) 1
Corneal reflex (eye blink when cornea is lightly touched with
cotton)
1
Startle reflex (motor response to snapping a clipboard ) 1
Seizures, myoclonus, myodystony 1
Total maximum points 18
Final score: 13–18= severe injury; 7–12= moderate injury; 1–6= mild injury.
A general summary of the evaluations commonly used to assess neurological
severity in experimental models. This table can be modified to contain
particular tests that are pertinent to the experimental design being used.
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namic and dependent on the severity of the initial insult,
the precise temporal and physical properties of these re-
covery mechanisms vary.
Choosing functional outcome measures
When evaluating post-stroke deficits and subsequent re-
covery in an animal model, it is essential to identify
functional assessments that have translational relevance
to the clinic. Several considerations that must be made
when choosing behavioural tests include the sensitivity
of the test to the damage incurred, the time required to
pre-train and test animals, and the possible confounding
properties of the tests and testing schedule chosen. The
latter is especially important in studies of rehabilitation,
in which the tests themselves can affect post-stroke neu-
roplasticity [59].
Animal behavioural testing can be extremely time con-
suming, and requires an experienced researcher to adminis-
ter. Animals must be pre-trained on most tests, sometimes
for periods of several weeks. This reduces the confounding
effects of stress and fear on behaviour, and ensures collec-
tion of reliable data. Following training, it is important that
animals are tested in an experimenter-blind fashion to
avoid test interpretation bias. Administration time varies
greatly between tests, and analysis can be laborious. Many
forelimb function assessments involve filming the test for
later detailed video analysis. Together with the fact that ex-
perimental animals are usually kept on a strict light:dark
schedule, these factors all affect the logistical feasibility of
any experimental study, often requiring multiple cohorts to
achieve the desired number of replicates.
Several behavioural tests of forelimb function have
been characterized in rat stroke models; the most com-
monly used are described below (see Table 3 for sum-
mary). Each test is sensitive to measuring deficits
associated with a particular area of damage, therefore it
is useful to employ a battery of tests to capture various
aspects of damage and recovery [97]. Simpler tests of
gross motor function categorized by ordinal scoring
scales are often employed as post-surgical screening
tools, to ensure surgical success and to stratify animals
into groups based on initial post-stroke deficit [76,87].
Because it is important that the animals have been accli-
mated to the experimenter performing the tests, when
possible, one experimenter should administer the test on
all testing days. If this is not feasible then steps should
be taken to ensure inter-experimenter reliability. Prior to
experimental stroke, it is useful to obtain baseline per-
formance by pre-testing.
Neurological severity score
The neurological severity score (NSS) is a broad meas-
ure of functional ability following experimental stroke.The NSS is compiled from scores on up to 20 tests
measuring reflexes, balance, sensory responses, and
motor functions [49,75,79]. A list of tests and observa-
tions are used to assign a score (maximum score indi-
cates severe deficits) that encompasses animals’ posture,
startle reflex, circling, and more (see Table 4).
Cylinder test
The cylinder test is widely used to evaluate spon-
taneous forelimb use during exploratory behaviour
[26,27,43,56,65,82,84,85,98,99]. First described by Schallert
et al. [100], this test is based on the observation that rats
explore vertical surfaces by lifting and bracing themselves
with their forequarters. An intact animal typically uses
both forelimbs equally for support, however following
Figure 3 The Schallert cylinder test [100] is performed by placing the rat into a clear plastic cylinder and analysing the proportion of
contralesional limb use during exploring and rearing activities.
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paired forelimb.
To perform the test, the animal is placed into a transpar-
ent plastic cylinder which encourages vertical exploration
(Figure 3). The animal is then video recorded while rear-
ing and exploring, generally for five to ten minutes or for
a predetermined number of rears. The ratio of wall place-
ments observed for the intact and impaired limb is deter-
mined by slow motion video analysis, and used to
calculate the percent usage of the impaired forelimb. Mul-
tiple camera angles and mirrors can be used to obtain
additional measurements, such as use of limbs during
weight bearing and landing. This test requires minimal
training (1–2 exposures), is easy to administer, and takes a
moderate amount of time to analyse.Reaching tests
The Montoya staircase test [101] is used to assess fore-
limb sensorimotor capacity, dexterity, and coordination
[27,57,76,78,82,84-86]. Animals are placed into an appar-
atus consisting of an elevated platform with seven des-
cending steps on either side (Figure 4). Each step is baited
with multiple palatable sucrose pellets, at progressively
deeper levels. Animals are generally given 15 minutes to
attempt to reach all pellets. In order to consume pellets
they must make a successful dexterous movement requir-
ing motor function and sensory feedback. Based on the
number and position of remaining pellets at the conclu-
sion of the 15 minute interval, the staircase test allows for
bilateral measurement of forelimb extension and grasping
skills. Pre-training on this test is extensive (2 weeks) and
Figure 4 The Montoya staircase test [101] measures dexterity and sensorimotor function by analysing pellet reaching behaviour. Rats
are placed into apparatus with seven descending steps on each side. Steps are baited with sucrose pellets to encourage reaching.
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time for administration and analysis of the results is
minor.
An alternative test used to assess forelimb function is
the single pellet reaching task. In this test, animals are
presented with a single pellet at a time, which must be
accessed by reaching through a slot [77,86], sometimes
at increasingly difficult distances [90]. This test allows
for more in-depth analysis of the animal’s performance,
as reaching attempts (as well as successes) can be
recorded. Accuracy can be determined using the equa-
tion: (number of successful reaches)/(total number of
reaching attempts) × 100. Video analysis can be done to
perform more in-depth kinematic analyses.Horizontal ladder test
The horizontal ladder test is used to assess skilled loco-
motor movements including stepping, placing, and inter-
limb coordination [27,43,57,78,83,84,86]. First describedFigure 5 The horizontal ladder test is used to assess forelimb functio
number of foot slips is determined by video analysis.by Metz & Wishaw [67], it offers comprehensive qualita-
tive and quantitative analysis of post-stroke condition.
The apparatus is a horizontally positioned ladder which
the animal crosses to escape aversive stimuli (noise and
light) (Figure 5). The spacing between the rungs of the
ladder is variable and can be changed to prevent the ani-
mal from learning either the absolute or relative location
of the rungs. The animal is video recorded while crossing
the apparatus, to determine the number of foot slips made
by each limb. Training on this test is minimal, while ana-
lysis can be moderately time intensive due to the video
analysis required.
Forelimb flexion test
The forelimb flexion test was developed by Bederson
et al. [102] to examine upper body posture while the ani-
mal is suspended by the tail. The test involves suspend-
ing a rat above the home cage or a table top and
observing the position of the impaired forelimb. Intact
animals extend both forelimbs directly toward then when crossing a platform of unevenly spaced rungs. The
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contralateral forelimb (at a 45–180 degree angle to the
body). Depending on stroke severity, this is sometimes
accompanied by torso twisting. Posture is normally
assigned a score from 0–2, wherein 0 = no flexion, 1 =
flexion of the forelimb, and 2 = forelimb flexion with
twisting of the torso. This test requires no pre-training,
and is very fast to administer.
Forelimb placing tests
The forelimb placing tests are used to examine sensori-
motor integration in response to tactile and propriocep-
tive stimuli [103]. To test forelimb function, a rat is held
by the torso with 3 limbs secured and the limb to be
tested hanging freely. The vibrissae or wrist of the ani-
mal is brushed against the edge of a table several times
to test vibrissae- and tactile-stimulated forelimb placing,
respectively. In intact animals, this stimulation elicits the
response of placing the forelimb being stimulated on the
table (Figure 6). Neurological damage from experimental
stroke causes this response to be impaired. This test
requires approximately 4–5 pre-exposures for acclima-
tion, and administration of this test is fast.
Discussion
With an increasingly aging population, high incidence of
stroke, and few effective medical interventions, it is vital
to gain a better understanding of the mechanisms
underlying functional recovery in order to refine existing
rehabilitative therapies and to develop new techniques.
In order to understand the mechanisms underlying re-
habilitation, animal models are of critical importance.
Addressing all aspects of human stroke using any givenFigure 6 Forelimb placing tests involves eliciting a response from eit
while the remaining one is tested for the ability to place the forelimb on tanimal model will never be possible, but many have
proven indispensible for contributing to our understand-
ing of the mechanisms underlying ischemic and neuro-
plastic processes.
While animal models remain critical to basic stroke re-
search, there are limitations in the translation of research
findings to clinical practice. As with other experimental
conditions, stroke models represent a simplified version of
an extremely complex human condition. Gender, age, pre-
stroke condition, stroke severity, and co morbidities are
highly variable in the clinical population, but tightly con-
trolled in experimental studies. The amount of damage
and subsequent severity of impairment are also disjointed
between the animal and human population, as animals
both require and can survive more severe neurological
damage in order to produce relevant functional deficits.
Furthermore, inherent complications of stroke models
outlined must be appreciated.
With the plethora of variables to consider at each step
when examining post-stroke rehabilitation, modeling re-
habilitation presents a major challenge and remains fun-
damentally different from the clinic. Stroke patients
undergoing CIMT receive supervised, assisted, and
highly motivated rehabilitation with trained experts.
Experimental rehabilitation is largely hands-off, and ani-
mals are more difficult to motivate. Decisions must be
made to best represent the validity of a model with re-
spect to a particular aspect of the therapy. Such deci-
sions may result in compromises in the intensity of the
therapy, or the use of bilateral rather than unilateral
stimulation, in order to address stress and behavioural
pressure. However, cortical reorganization and func-
tional benefit may still share underlying processes toher tactile or vibrissae stimulation. Three limbs are held secure
he table edge in response to stimulation.
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constraint is considered the tool that induces the benefi-
cial use of the impaired limb and discourages learned
non-use [18].
As is the case in clinical evaluations, efficacy of rehabili-
tation depends on the use of functional measures. In order
to accurately assess a model of rehabilitation, it is import-
ant that researchers choose appropriate outcome measures
that will be sensitive both to the nature of the damage
caused by the stroke model, and to possible improvements
that could be attributed to the therapy. Furthermore, tests
of gross motor movement (e.g. forelimb placing) and those
that use ordinal scales (e.g. forelimb postural reflex) can
result in a ‘ceiling effect’ , wherein subjects’ performance
scores return to normal levels while some impairment
remains undetected. This is a challenge faced by clinical
researchers, who use scaled outcome measures like the
Barthal index (BI), motor activity log (MAL), and func-
tional independence measure (FIM), also susceptible to
the ceiling effect [21,104-106]. Thus, it is important that
a researcher chooses a battery of tests that encompass a
variety of movement types. Importantly, behavioural out-
come is a culmination of a number of processes that can
be affected by various aspects, including recovery, com-
pensatory strategies, stress, anxiety, and general well-
being. This creates a complicated web of interactions that
may confound results and, as is the case with clinical
evaluations, requires careful consideration.Conclusions
Animal models will never perfectly mimic the human
condition, but are intended to guide scientific under-
standing and provide insight into specific processes
involved with post-ischemic recovery. As such, several
studies have already proved essential in identifying pro-
cesses that may underlie the functional improvements
resulting from CIMT, and the body of literature con-
tinues to grow. The remaining challenge is to ensure
that this experimental research is effectively translated in
order to capitalize on existing knowledge, identify com-
mon findings, and ensure positive collaborations toward
improving post-stroke recovery.
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